Cardiotonic modulation in heart failure: Insights from traditional Chinese medicine

Journal of the American College of Cardiology

Volumn 62, Issue 12, 2013, Pages 1073-1074

  Tang, W H Wilson ^a   Huang, Yanming ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

chronic heart failure; controlled clinical trial; qili qiangxin capsules

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; CARDIOTONIC AGENT; DIGITALIS; DIURETIC AGENT; ENOXIMONE; FLAVONOID; GINSENOSIDE; HERBACEOUS AGENT; PHENOL DERIVATIVE; PHYTOSTEROL; PLACEBO; QILI QIANGXIN; TRITERPENOID; UNCLASSIFIED DRUG;

CHEMICAL COMPOSITION; CHINESE MEDICINE; DRUG EFFICACY; DRUG RESPONSE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; NEW YORK HEART ASSOCIATION CLASS; NOTE; PATENT; PRIORITY JOURNAL; QUALITY OF LIFE; RISK BENEFIT ANALYSIS; SYSTOLIC HEART FAILURE;

EID: 84883751402     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2013.05.028     Document Type: Editorial

References (14)

1. A. Tachjian, V. Maria, and A. Jahangir Use of herbal products and potential interactions in patients with cardiovascular diseases J Am Coll Cardiol 55 2010 515 525
2. M.H. Pittler, R. Guo, and E. Ernst Hawthorn extract for treating chronic heart failure Cochrane Database Syst Rev 1 2008 CD005312
3. S.M. Zick, B.M. Vautaw, B. Gillespie, and K.D. Aaronson Hawthorn Extract Randomized Blinded Chronic Heart Failure (HERB CHF) trial Eur J Heart Fail 11 2009 990 999
4. D. Liang, and M. Zhang The thinking on TCM differential treatment of congestive heart failure J Tradit Chin Med 20 2000 44 47
5. X. Li, J. Zhang, and J. Huang A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of the effects of qili qiangxin capsules in patients with chronic heart failure J Am Coll Cardiol 62 2013 1065 1072
6. H. Xiao, Y. Song, Y. Li, Y.H. Liao, and J. Chen Qiliqiangxin regulates the balance between tumor necrosis factor-alpha and interleukin-10 and improves cardiac function in rats with myocardial infarction Cell Immunol 260 2009 51 55
7. W. Liu, J. Chen, and T. Xu Qiliqiangxin improves cardiac function in spontaneously hypertensive rats through the inhibition of cardiac chymase Am J Hypertens 25 2012 250 260
8. Y. Zou, L. Lin, and Y. Ye Qiliqiangxin inhibits the development of cardiac hypertrophy, remodeling, and dysfunction during 4 weeks of pressure overload in mice J Cardiovasc Pharmacol 59 2012 268 280
9. L.P. Kang, Y. Zhao, and H.S. Yu Identification of chemical constituents in qiliqiangxin capsule by UPLC-Q-TOF/MS(E) Yao Xue Xue Bao 46 2011 1231 1236
10. W. Withering An Account of the Foxglove and Some of Its Medical Uses: With Practical Remarks on Dropsy and Other Diseases 1785 M. Sweeny Birmingham, United Kingdom
11. B.D. Lowes, M. Higginbotham, and L. Petrovich Low-dose enoximone improves exercise capacity in chronic heart failure. Enoximone Study Group J Am Coll Cardiol 36 2000 501 508
12. J.W. Park, R. Heinzler, and J.H. Wirtz Low-dose enoximone therapy in pre-transplant patients: hemodynamic, echocardiographic, and neurohumoral findings Z Kardiol 83 Suppl 2 1994 49 53
13. M. Metra, E. Eichhorn, and W.T. Abraham Effects of low-dose oral enoximone administration on mortality, morbidity, and exercise capacity in patients with advanced heart failure: the randomized, double-blind, placebo-controlled, parallel group ESSENTIAL trials Eur Heart J 30 2009 3015 3026
14. X. Li, H. Chen, W. Jia, and G. Xie A metabolomics-based strategy for the quality control of traditional Chinese medicine: shengmai injection as a case study Evid Based Complement Alternat Med 2013 2013 836179